Cite
MLA Citation
M. L. Wang et al.. “S209: PRIMARY RESULTS FROM THE PHASE 3 SHINE STUDY OF IBRUTINIB IN COMBINATION WITH BENDAMUSTINE-RITUXIMAB (BR) AND R MAINTENANCE AS A FIRST-LINE TREATMENT FOR OLDER PATIENTS WITH MANTLE-CELL LYMPHOMA.” HemaSphere, vol. 6, n.d., pp. 110–111. http://access.bl.uk/ark:/81055/vdc_100158013909.0x00001b